ABSTRACT
Animal models of diseases are invaluable tools of modern medicine. More than forty years have passed since the first successful experiments and the spectrum of available models, as well as the list of methods for creating them, have expanded dramatically. The major step forward in creating specific disease models was the development of gene editing techniques, which allowed for targeted modification of the animal's genome. In this review, we discuss the available tools for creating transgenic animal models, such as transgenesis methods, recombinases, and nucleases, including zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), and CRISPR/Cas9 systems. We then focus specifically on the models of atherosclerosis, especially mouse models that greatly contributed to improving our understanding of the disease pathogenesis and we outline their characteristics and limitations.
Subject(s)
Humans , Animals , Male , Female , Rabbits , Animals, Genetically Modified , Genetic Engineering/methods , Disease Models, Animal , Atherosclerosis/physiopathology , Transcription Activator-Like Effector Nucleases/metabolism , Gene Transfer Techniques , Biomedical Research/methods , Atherosclerosis/geneticsABSTRACT
Objective: CRISPR/Cas9 technology provides a powerful tool for targeted modification of genomes. In this system, a donor DNA harboring two flanking homology arms is mostly used for targeted insertion of long exogenous DNA. Here, we introduced an alternative design for the donor DNA by incorporation of a single short homology arm into a circular plasmid
Materials and Methods: In this experimental study, single homology arm donor was applied along with a single guide RNA [sgRNA] specific to the homology region, and either Cas9 or its mutant nickase variant [Cas9n]. Using Pdx1 gene as the target locus the functionality of this system was evaluated in MIN6 cell line and murine embryonic stem cells [ESCs]
Results: Both wild type Cas9 and Cas9n could conduct the knock-in process with this system. We successfully applied this strategy with Cas9n for generation of Pdx1GFP knock-in mouse ESC lines. Altogether, our results demonstrated that a combination of a single homology arm donor, a single guide RNA and Cas9n is capable of precisely incorporating DNA fragments of multiple kilo base pairs into the targeted genomic locus
Conclusion: While taking advantage of low off-target mutagenesis of the Cas9n, our new design strategy may facilitate the targeting process. Consequently, this strategy can be applied in knock-in or insertional inactivation studies
Subject(s)
Gene Knock-In Techniques , Embryonic Stem Cells , Gene Targeting , Genetic Engineering/methods , Homologous Recombination/genetics , MiceABSTRACT
The hepatitis C virus (HCV) encodes approximately 10 different structural and non-structural proteins, including the envelope glycoprotein 2 (E2). HCV proteins, especially the envelope proteins, bind to cell receptors and can damage tissues. Endothelial inflammation is the most important determinant of fibrosis progression and, consequently, cirrhosis. The aim of this study was to evaluate and compare the inflammatory response of endothelial cells to two recombinant forms of the HCV E2 protein produced in different expression systems (Escherichia coli and Pichia pastoris). We observed the induction of cell death and the production of nitric oxide, hydrogen peroxide, interleukin-8 and vascular endothelial growth factor A in human umbilical vein endothelial cells (HUVECs) stimulated by the two recombinant E2 proteins. The E2-induced apoptosis of HUVECs was confirmed using the molecular marker PARP. The apoptosis rescue observed when the antioxidant N-acetylcysteine was used suggests that reactive oxygen species are involved in E2-induced apoptosis. We propose that these proteins are involved in the chronic inflammation caused by HCV.
Subject(s)
Humans , Hepacivirus/metabolism , Human Umbilical Vein Endothelial Cells/immunology , Human Umbilical Vein Endothelial Cells/pathology , Nitric Oxide/metabolism , Tumor Necrosis Factor-alpha/metabolism , Viral Envelope Proteins/metabolism , Apoptosis/genetics , Arginase/metabolism , Cell Survival , Escherichia coli/metabolism , Fibrosis , Gene Expression/genetics , Genetic Engineering/methods , Genetic Vectors/metabolism , Hepacivirus/immunology , Hepatitis C Antigens/metabolism , Inflammation/metabolism , /metabolism , Pichia/metabolism , Plasmids/metabolism , Recombinant Proteins , Vascular Endothelial Growth Factor A/metabolismABSTRACT
Phytic acid, the major storage form of phosphorus in plant seeds is degraded by the phytases to yield inositol and free phosphate, contributing thereby to the improved bioavailability of phytate phosphorus and essential minerals in plant foods and simultaneous reduction in phosphorus pollution of the terrestrial and aquatic ecosystems. As a possible strategy for altering seed phytate levels, the approach involving reduction of phytate content by ectopically expressing endogenous phytase gene during seed development of soybean (Glycine max L. cv. Pusa-20) was attempted in the present study. Semi-quantitative RT-PCR revealed the maximum expression of phytase gene transcripts in germinating cotyledons (~10 days after germinations), compared to other vegetative tissues. A full-length phytase cDNA was amplified from the germinating seedlings by splicing by overlap extension (SOE)-PCR and its sequence analysis revealed an open-reading-frame of 1644 bp, including an N terminal signal peptide of 28 amino acids. Predicted amino acid sequence (547-aa) of molecular mass 62 kDa on alignment with related purple acid phosphatases in other plants shared five conserved domains and seven invariant amino acids involved in coordination of the metals in the binuclear center of purple acid phosphatases. Owing to a large number of E. coli low-usage codons in soybean phytase gene, the modified gene was cloned into a prokaryotic expression vector pET-28a (+) and its expression in E. coli was confirmed by SDS-PAGE and Western blot analysis. Bioassay of the crude expression product in E. coli revealed a functional phytase gene, showing a great potential for developing low phytate transgenic soybean through its seed-specific overexpression in the early stages of seed development.
Subject(s)
6-Phytase/biosynthesis , 6-Phytase/chemistry , 6-Phytase/genetics , Amino Acid Sequence , Cloning, Molecular , Codon/genetics , DNA, Complementary/genetics , Escherichia coli/genetics , Gene Expression , Gene Expression Regulation, Plant , Genetic Engineering/methods , Minerals/metabolism , Molecular Sequence Data , Organ Specificity , Phosphorus/metabolism , Phylogeny , Seedlings/genetics , Sequence Homology , Glycine max/enzymology , Glycine max/genetics , Glycine max/metabolismABSTRACT
Genetically Modified Organisms (GMO) could be the answer for many relevant problems affecting crops. However, improving crops through GMO is also often associated with safety concerns, environmental risks and health issues due to the presence of foreign DNA. These limitations have prompted the development of alternative technologies. Recently, cisgenesis and intragenesis have been developed as new tools aimed to modify crops. While cisgenesis involves genetic modification using a complete copy of natural genes with their regulatory elements that belong exclusively to sexually compatible plants, intragenesis refers to the transference of new combinations of genes and regulatory sequences belonging to that particular species. So far, application of cisgenesis and intragenesis as alternatives to conventional transgenesis are limited to a few species, mainly due to the lack of knowledge of the regulatory sequences required. The grape is one of the most cultivated crops worldwide and is the most economically relevant crop in Chile. Its genomic sequence has been completed, making available new sources of information to improve grape traits by genetic manipulation. This review is focused on the current alternatives to transgenesis in plants, including new approaches to develop marker-free crops, their application to economically relevant crops and future perspectives in the area. Also, the identification of grapevine promoters with a wide range of expression profiles is shown. The expression pattern of these genes was analyzed in different tissues and developmental stages, as well as under several stresses and stimuli, giving a broad range of expression patterns, including genes expressed exclusively during ripening, in response to sugars, senescence and biotic stress, among others. Genes with strong and constitutive expression were also identified. Functional analysis using reporter genes has been conducted in order to confirm the promoter's transcription activity, opening new possibilities for developing cisgenic/intragenic grapevines.
Subject(s)
Crops, Agricultural/genetics , Genetic Engineering/methods , Hybridization, Genetic/genetics , Plants, Genetically Modified/genetics , ChileABSTRACT
A Periodontite é uma doença inflamatória que se manifesta clinicamente com a perda dos tecidos de suporte periodontal, incluindo osso alveolar, ligamento periodontal e cemento. Um dos objetivos do tratamento periodontal é a obtenção da regeneração dos tecidos visando reparar os danos ocasionados pela doença. As principais terapias utilizadas para esse fim incluem condicionamento da superfície radicular, enxertos e substitutos ósseos, fatores de crescimentos, proteínas derivadas da matriz do esmalte e regeneração tecidual guiada. As células-tronco são células com capacidade de proliferação, autorrenovação e diferenciação em células especializadas que poderiam regenerar os tecidos e os órgãos. As células-tronco podem ser classificadas como embrionárias ou não embrionárias, conhecidas também como células-tronco adultas, e estas são divididas em hematopoiéticas e mesenquimais. Pesquisas recentes têm demonstrado que populações de célula-tronco adulta residem no ligamento periodontal humano. Avanços da bioengenharia abrem caminho para o desenvolvimento de novas terapias para obtenção de um sucesso efetivo para a regeneração dos tecidos periodontais.
Subject(s)
Humans , Bioengineering , Periodontal Diseases/therapy , Genetic Engineering/methods , Guided Tissue Regeneration, Periodontal , Stem Cell Transplantation , Stem CellsABSTRACT
Chilli fruit is highly susceptible to anthracnose infection at the stage of harvest maturity, due to which the fruit yield in the leading commercial variety Byadgi is severely affected. Field studies on screening of several varieties for resistance to anthracnose have shown that a variety of chilli AR-4/99K is resistant to anthracnose infection. In many crops, resistance to fungal attack has been correlated with PGIP activity in developing fruits based on which transgenic varieties have been developed with resistance to fungi. The present study was carried out to determine whether anthracnose resistance in AR-4/99K was due to the increased levels of PGIP alone and/ or due to differences, if any, in the properties of PGIP. Hence, a comparative study of the properties of polygalacturonase inhibitor protein (PGIP) isolated from fruits of anthracnose resistant chilli var AR-4/99K and a susceptible variety Byadgi was conducted with the objective of utilizing the information in genetic transformation studies. Both the PGIPs from anthracnose resistant and susceptible varieties of chilli exhibited similarities in the elution pattern on Sephadex gel, DEAE cellulose, PAGE and SDS-PAGE. The two PGIPs were active over a wide range of pH and temperature. Both PGIPs showed differential inhibitory activity against polygalacturonase (PG) secreted by Colletotrichum gleosporoides, C. capsici, C. lindemuthianum, Fusarium moniliforme and Sclerotium rolfsii. The inhibitory activity of PGIP from both resistant and susceptible varieties was the highest (82% and 76%, respectively) against the PG from Colletotrichum capsici, a pathogen causing anthracnose rot of chilli, while the activity was lower (1.27 to 12.3%) on the other fungal PGs. Although PGIP activity decreased with fruit maturation in both the varieties, the resistant variety maintained a higher activity at 45 days after flowering (DAF) as compared to the susceptible variety which helped it to overcome the infection by anthracnose as against the susceptible variety (Byadgi) in which PGIP activity was drastically reduced at maturity. The molecular mass of PGIP as determined by SDS-PAGE was found to be 37 kDa. N-terminal sequence analysis of the PGIP showed the first six amino acid residues from N-terminal end were Asp-Thr-His-Lys-Ser-Glu (DTHKSE), respectively. The similarities in properties of the two PGIPs support the earlier findings that resistance of AR-4/99K to anthracnose fungus is a result of its higher PGIP activity at maturity.
Subject(s)
Amino Acid Sequence , Ascomycota/metabolism , Capsicum/metabolism , Cellulose/chemistry , Chemistry, Pharmaceutical/methods , Dose-Response Relationship, Drug , Drug Design , Genetic Engineering/methods , Hydrogen-Ion Concentration , Molecular Sequence Data , Plant Diseases/genetics , Plant Diseases/microbiology , Plant Extracts/pharmacology , Polygalacturonase/antagonists & inhibitors , Polygalacturonase/chemistry , Sequence Analysis, ProteinABSTRACT
Increasing from day to day tendency of human societies to plant based drug usage increased demand of secondary metabolite application. Although artificial production of these compounds greatly progressed, but the only way to achieve these fine medicinal compounds has been to extract them from plant resources. Alkaloid field, although very old, is still in its infancy with regard to being fully understood, and biotechnologically exploited. Up to now, approximately 5000 different alkaloids, in 15% of plants that belong to 150 families, have been recognized, that tropane alkaloids such as hyosyamine, scopolamine, atropine and cocaine, with a broad medical usage are a class of them. Industrial tropane alkaloid production by modern techniques such as cell and tissue culture, somatic hybridization, metabolic engineering and commercial large scale culture, is highly concerned nowadays and in this review, the authors have tried to point out some of the results obtained by application of these techniques
Subject(s)
Alkaloids/biosynthesis , Culture Techniques , Plants, Genetically Modified , Technology, Pharmaceutical , Genetic Engineering/methods , BioreactorsABSTRACT
ALP2 gene encoding alkaline protease cloned from Aureobasidium pullulans HN2-3 was ligated into the surface display plasmid and expressed in the cells of the yeast Yarrowia lipolytica. The expressed alkaline protease was immobilized on the yeast cells. The activity of the immobilized enzyme with 6 His tag was found to be significantly higher than that of without 6 His tag. The immobilized enzyme showed lower optimal temperature and a lower affinity for azocasein than the free enzyme purified from A. pullulans HN2-3. The thermal stability of the immobilized enzyme enhanced and the pH stability decreased, compared to that of the free enzyme.
Subject(s)
Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Caseins/chemistry , Cations , Cell Membrane/metabolism , Cloning, Molecular , Endopeptidases/chemistry , Endopeptidases/genetics , Enzymes, Immobilized/chemistry , Fungi/enzymology , Gene Expression Regulation, Fungal , Genetic Engineering/methods , Hydrogen-Ion Concentration , Ions , Kinetics , Models, Biological , Temperature , Yarrowia/enzymology , Yarrowia/geneticsABSTRACT
A shuttle vector for Escherichia coli and Giardia lamblia was modified to produce a reporter plasmid, which monitors the expression of prescribed gene in G. lamblia by measuring its luciferase activity. Promoter regions of the gap2 gene, one of the genes induced during encystation, were cloned into this plasmid, and the resultant constructs were then transfected into trophozoites of G. lamblia. Transgenic trophozoites containing one of the 3 gap2-luc reporters were induced to encystation, and characterized with respect to gap2 gene expression by measuring their luciferase activities. Giardia containing a gap2-luc fusion of 112-bp upstream region showed full induction of luciferase activity during encystation.
Subject(s)
Animals , Transfection/methods , Time Factors , Recombinant Fusion Proteins/analysis , Promoter Regions, Genetic/physiology , Plasmids , Luciferases/genetics , Life Cycle Stages/physiology , Giardia lamblia/genetics , Genetic Engineering/methods , Genes, Reporter/genetics , Genes, Protozoan/genetics , Gene Order , Gene Expression/genetics , GTPase-Activating Proteins/genetics , Blotting, Southern/methodsSubject(s)
Base Sequence , Cloning, Molecular , Deoxyribonucleases, Type II Site-Specific/genetics , Genetic Engineering/methods , Genetic Vectors , Models, Genetic , Molecular Sequence Data , Mutagenesis, Insertional , Oligodeoxyribonucleotides/chemical synthesis , Phylogeny , Plasmids , Polymerase Chain Reaction , Restriction MappingABSTRACT
La caries es una enfermedad infecciosa, transmisible y sacarosa dependiente. Su etiología está basada en los postulados de Koch. La patología molecular muestra que el ácido láctico producido por la lactatodehidrogenasa del Streptococcus mutans es el responsable final de la desmineralización del esmalte. Objetivos: revisar en la literatura la propuesta de una nueva forma de prevenir la enfermedad: la "terapia de reemplazo" (basada en ingeniería genética ya que se remueve al Streptococcus mutans el gen que codifica a la lactato deshidrogenasa), con el fin de discutir aspectos éticos y de seguridad al implantar la nueva cepa para colonizar los nichos de la flora nativa. Métodos: buscar, revisar y criticar bibliografía obtenida de forma tradicional y publicadas en internet. Resultados: la habilidad de la bacteria no cariogénica para desplazar a la cepa nativa y colonizar su nicho está bien documentada en literatura pero no se encuentran respuesta sobre la estabilidad de la cepa y sobre potenciales riesgos que cuestionen la seguridad del proceso al ser utilizado por todos. Conclusiones: actualmente la terapia de reemplazo debe considerarse como una innovadora propuesta para la prevención de la caries, con perspectivas de ser una hipótesis demostrable que implica un costo beneficio favorable para su aplicación masiva
Subject(s)
Dental Caries , Genetic Engineering/methods , Streptococcus mutans , Lactic Acid/chemistry , Dental Caries , Dental Plaque , Tooth Demineralization/etiology , Hydrogen-Ion Concentration , Streptococcal Infections/etiology , Streptococcal Infections/prevention & control , Streptococcal Infections/transmission , L-Lactate DehydrogenaseABSTRACT
The initial attempts at hyper-expressing buffalo/goat growth hormone (GH)-ORFs in Escherichia coli directly under various strong promoters were not successful despite the presence of a functional gene. High level expression of GH was achieved as a fusion protein with glutathione-S-transferase (GST). To produce native GH in an unfused state, we adapted an established strategy of two-cistronic approach in our system. In this strategy, utilizing one of the highly efficient reported sequences as the first cistron led to a nearly 1000-fold enhancement in the level of expression under an E. coli promoter (trc). In search of a newer first-cistron sequence as well as to see the generality of the two-cistronic approach, we explored the ability of different lengths of a highly expressing natural gene to act as an efficient first cistron. Surprisingly, GST, which is naturally highly expressible in E. coli, could not be fitted into a successful two-cistronic construct. In addition, placement of the entire two-cistronic expression cassette (which had earlier given high-level GH expression under trc promoter) under the T7 promoter in E. coli failed to hyper-express GH. These results suggest that the successful exploitation of the two-cistron arrangement for hyper-expression of eukaryotic ORFs in bacteria is not as straightforward as was previously thought. It appears probable that factors such as the sequence context, together with the length and codons used in the first cistron are important as well.
Subject(s)
Amino Acid Sequence , Animals , Base Sequence , Blotting, Western , Buffaloes/genetics , Escherichia coli/genetics , Gene Expression , Genes/genetics , Genetic Engineering/methods , Genetic Vectors/genetics , Goats/genetics , Growth Hormone/biosynthesis , Molecular Sequence Data , Protein BiosynthesisABSTRACT
The ability to introduce genetic modifications in the germ line of complex organisms has been a long-standing goal of those who study developmental biology. In this regard, the mouse, a favorite model for the study of the mammals, is unique: indeed not only is it possible since the late seventies, to add genes to the mouse genome like in several other complex organisms but also to perform gene replacement and modification. This has been made possible via two technological breakthroughs: 1) the isolation and culture of embryonic stem cells (ES), which have the unique ability to colonize all the tissues of an host embryo including its germ line; 2) the development of methods allowing homologous recombination between an incoming DNA and its cognate chromosomal sequence (gene ''targeting''). As a result, it has become possible to create mice bearing null mutations in any cloned gene (knock-out mice). Such a possibility has revolutionized the genetic approach of almost all aspects of the biology of the mouse. In recent years, the scope of gene targeting has been widened even more, due to the refinement of the knock-out technology: other types of genetic modifications may now be created, including subtle mutations (point mutations, micro deletions or insertions, etc.) and chromosomal rearrangements such as large deletions, duplications and translocations. Finally, methods have been devised which permit the creation of conditional mutations, allowing the study of gene function throughout the life of an animal, when gene inactivation entails embryonic lethality. In this paper, we present an overview of the methods and scenarios used for the programmed modification of mouse genome, and we underline their enormous interest for the study of mammalian biology
Subject(s)
Animals , Mice , Genetic Engineering/methods , Genome , Mice, Knockout/genetics , Recombination, Genetic , Stem Cells , Embryonic Structures , Gene Targeting , Mice, Transgenic , Mutagenesis , MutationABSTRACT
Analizando los diferentes empleos que se hacen del término manipulación, y la descripción y clasificación que del mismo hace la literatura científica, se entra a considerar la manipulación personal como manipulación biológica en el campo específico de la ingeniería genética (diferencia entre manipulación e ingeniería genética, objeto de esta manipulación, finalidades) y las diferentes manipulaciones a las que está sometido el ser humano: en el nivel biológico (manipulación del cerebro, trasplante de órganos), nivel quirúrgico (trasplante de ovarios, fecundación in vitro) y en el nivel de los genes (elección del sexo de los hijos, terapia de los genes, reproducción asexual y eufenética). Se finaliza con algunas pautas bioéticas para abordar el problema de la manipulación (manipulación y ciencia, manipulación y Bioética, el valor ético de la persona como dimensión crítica de toda manipulación y elpapel del bioeticista y el futuro del hombre).
Subject(s)
Bioethics , Genetic Engineering/methods , Genetic Engineering/trendsABSTRACT
A inocuidade ecológica e alimentar dos transgênicos - organismos que, por manipulação genética, têm adicionado ao seu patrim6nio gnético genes de outros organismos e transmitem tais modificações a sua descendência - é assunto fundamentalmente técnico que pede resposta experimental e científica aberta ás discussões desprovidas de ideologia ou opção religiosa. Ela está no centro de um debate internacional, cuja resolução envolve a saúde dos consumidores, e economia dos produtores e a orientação política dos governos. No Brasil, em particular, tem mobilizado setores expressivos da comunidade científica a partir das decisões equivocadas da CNTBio (Comiss`ao Técnica Nacional de Biossegurança) que autorizou o plantio, e consequentemente, a comercialização e o consumo da soja Roundup Ready© (soja RR) , dispensando estudos de impacto ambiental e respectivo relatório d impacto em meio ambiente.
Subject(s)
Glycine max/genetics , Plants, Genetically Modified/genetics , Crop Production , Bioethics , Biotechnology , Brazil , Genetic Engineering/methods , Food LabelingABSTRACT
The administration of baculoviruses to insects for bioassay purposes is carried out, in most cases, by contamination of food surfaces with a known amount of occlusion bodies (OBs). Since per os infection is the natural route of infection, occluded recombinant viruses containing crystal protein genes ( cry1Ab and cry1Ac ) from Bacillus thuringiensis were constructed for comparison with the baculovirus prototype Autographa californica nucleopolyhedrovirus (AcNPV). The transfer vector pAcUW2B was used for construction of occluded recombinant viruses. The transfer vector containing the crystal protein genes was cotransfected with linearized DNA from a non-occluded recombinant virus. The isolation of recombinant viruses was greatly facilitated by the reduction of background "wild type" virus and the increased proportion of recombinant viruses. Since the recombinant viruses containing full-length and truncated forms of the crystal protein genes did not seem to improve the pathogenicity of the recombinant viruses when compared with the wild type AcNPV, and in order to compare expression levels of the full-length crystal proteins produced by non-occluded and occluded recombinant viruses the full-length cry1Ab and cry1Ac genes were chosen for construction of occluded recombinant viruses. The recombinant viruses containing full-length and truncated forms of the crystal protein genes did not seem to improve its pathogenicity but the size of the larvae infected with the recombinant viruses was significantly smaller than that of larvae infected with the wild type virus